Panacea Biotec, a research based health management company, announced that the company has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO).

The company has been awarded for supply of 5.99 million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 & 2016 worth USD 13.49 million (equivalent to around Rs 835.2 million) to meet the requirements of global immunization program.

Shares of the company gained Rs 6.45, or 4.66%, to trade at Rs 144.90 at the BSE (12.22 p.m., Wednesday).